- Approval Id
- d8b0a4bd1303a57a
- Drug Name
- HERBESSER TABLET 30 MG
- Product Name
- HERBESSER TABLET 30 MG
- Approval Number
- SIN00428P
- Approval Date
- 1988-04-28
- Registrant
- TANABE PHARMA SINGAPORE PTE. LTD.
- Licence Holder
- MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong></p>
<ul class="dash">
<li>Angina pectoris, variant angina pectoris<br>
The usual adult dosage for oral use is 30 mg of diltiazem hydrochloride three times a day (90 mg/day). The dosage may be increased to 60 mg three times a day (180 mg/day), if necessary.</li>
<li>Essential hypertension (mild to moderate)<br>
The usual adult dosage for oral use is 30 to 60 mg of diltiazem hydrochloride three times a day (90 – 180 mg/day). The dosage may be adjusted depending on the patient’s age and symptoms.</li>
</ul>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>INDICATIONS</strong></p>
<ul class="dash">
<li>Angina pectoris, variant angina pectoris</li>
<li>Essential hypertension (mild to moderate)</li>
</ul>
- Contraindications
- <p><strong>CONTRAINDICATIONS (HERBESSER and HERBESSER 60 are contraindicated in the following patients.)</strong></p>
<ol class="decimalparen">
<li>Patients with severe congestive heart failure. [The symptoms of heart failure may be exacerbated.]</li>
<li>Patients with 2nd- or 3rd-degree atrioventricular block or sick sinus syndrome (continuous sinus bradycardia (less than 50 beats/minute), sinus arrest, sinoatrial block, etc.) [Excessive inhibition of sinus rhythm and cardiac conduction may occur.]</li>
<li>Patients with a history of hypersensitivity to any of the ingredients in the drug.</li>
<li>Pregnant women or women who may possibly be pregnant, etc. [See PRECAUTIONS – Use during Pregnancy, Delivery or Lactation – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>.]</li>
<li>Patients receiving ivabradine hydrochloride. [See “Drug Interactions” section – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>.]</li>
</ol>
- Atc Code
- C08DB01
- Atc Item Name
- diltiazem
- Pharma Manufacturer Name
- MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
